DK2158214T3 - Glukagonanaloger - Google Patents

Glukagonanaloger

Info

Publication number
DK2158214T3
DK2158214T3 DK08762369T DK08762369T DK2158214T3 DK 2158214 T3 DK2158214 T3 DK 2158214T3 DK 08762369 T DK08762369 T DK 08762369T DK 08762369 T DK08762369 T DK 08762369T DK 2158214 T3 DK2158214 T3 DK 2158214T3
Authority
DK
Denmark
Prior art keywords
glukagonanaloger
Prior art date
Application number
DK08762369T
Other languages
English (en)
Inventor
Ditte Riber
Eddi Meier
Jens Rosengren Daugaard
Trine Skovlund Ryge Neerup
Original Assignee
Zealand Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GB0711673A priority Critical patent/GB0711673D0/en
Priority to EP20070016032 priority patent/EP2025684A1/en
Priority to US18807P priority
Application filed by Zealand Pharma As filed Critical Zealand Pharma As
Priority to PCT/GB2008/002041 priority patent/WO2008152403A1/en
Application granted granted Critical
Publication of DK2158214T3 publication Critical patent/DK2158214T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/605Glucagons
DK08762369T 2007-06-15 2008-06-16 Glukagonanaloger DK2158214T3 (da)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GB0711673A GB0711673D0 (en) 2007-06-15 2007-06-15 Glucagon analogues
EP20070016032 EP2025684A1 (en) 2007-08-15 2007-08-15 Glucagon analogues
US18807P true 2007-10-24 2007-10-24
PCT/GB2008/002041 WO2008152403A1 (en) 2007-06-15 2008-06-16 Glucagon analogues

Publications (1)

Publication Number Publication Date
DK2158214T3 true DK2158214T3 (da) 2011-12-05

Family

ID=39709376

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08762369T DK2158214T3 (da) 2007-06-15 2008-06-16 Glukagonanaloger

Country Status (6)

Country Link
US (1) US7994122B2 (da)
EP (1) EP2158214B1 (da)
JP (1) JP5385266B2 (da)
AT (1) AT520714T (da)
DK (1) DK2158214T3 (da)
WO (1) WO2008152403A1 (da)

Families Citing this family (91)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8338368B2 (en) 2005-11-07 2012-12-25 Indiana University Research And Technology Corporation Glucagon analogs exhibiting physiological solubility and stability
US8454971B2 (en) 2007-02-15 2013-06-04 Indiana University Research And Technology Corporation Glucagon/GLP-1 receptor co-agonists
MX2010004298A (es) * 2007-10-30 2010-05-03 Univ Indiana Res & Tech Corp Compuestos que exhiben actividad antagonista de glucagon y agonista de glp-1.
EP2300035B1 (en) * 2008-06-17 2015-08-12 Indiana University Research and Technology Corporation Gip-based mixed agonists for treatment of metabolic disorders and obesity
AU2009260302B2 (en) 2008-06-17 2014-10-23 Indiana University Research And Technology Corporation Glucagon/GLP-1 receptor co-agonists
MX2011006315A (es) 2008-12-15 2011-09-22 Zealand Pharma As Analogos de glucagon.
ES2477880T3 (es) * 2008-12-15 2014-07-18 Zealand Pharma A/S Análogos del glucagón
WO2010070251A1 (en) 2008-12-15 2010-06-24 Zealand Pharma A/S Glucagon analogues
EP2370461B1 (en) 2008-12-15 2013-10-02 Zealand Pharma A/S Glucagon analogues
WO2010071807A1 (en) 2008-12-19 2010-06-24 Indiana University Research And Technology Corporation Amide based glucagon superfamily peptide prodrugs
KR20120087875A (ko) 2009-06-16 2012-08-07 인디애나 유니버시티 리서치 앤드 테크놀로지 코퍼레이션 Gip 수용체-활성 글루카곤 화합물
JP6054742B2 (ja) 2009-07-13 2016-12-27 ジーランド ファーマ アクティーゼルスカブ アシル化グルカゴン類似体
AR079344A1 (es) 2009-12-22 2012-01-18 Lilly Co Eli Analogo peptidico de oxintomodulina, composicion farmaceutica que lo comprende y uso para preparar un medicamento util para tratar diabetes no insulinodependiente y/u obesidad
JO2976B1 (en) 2009-12-22 2016-03-15 ايلي ليلي اند كومباني Oxyntomodulin peptide analogue ‎
US20130157953A1 (en) * 2010-01-20 2013-06-20 Zealand Pharma A/S Treatment of cardiac conditions
JP2013518115A (ja) 2010-01-27 2013-05-20 インディアナ ユニバーシティー リサーチ アンド テクノロジー コーポレーションIndiana University Research And Technology Corporation 代謝疾患及び肥満の治療のためのグルカゴンアンタゴニスト‐gipアゴニスト複合体及び組成物
WO2011107494A1 (de) 2010-03-03 2011-09-09 Sanofi Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
CN102933598A (zh) 2010-03-26 2013-02-13 诺沃—诺迪斯克有限公司 新型胰高血糖素类似物
MX336412B (es) 2010-03-26 2016-01-19 Novo Nordisk As Nuevos analogos de glucagon.
DE102010015123A1 (de) 2010-04-16 2011-10-20 Sanofi-Aventis Deutschland Gmbh Benzylamidische Diphenylazetidinone, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
AU2011247452B2 (en) 2010-04-27 2016-03-17 Zealand Pharma A/S Peptide conjugates of GLP-1 receptor agonists and gastrin and their use
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
AR081975A1 (es) * 2010-06-23 2012-10-31 Zealand Pharma As Analogos de glucagon
AU2011269430A1 (en) 2010-06-24 2013-01-10 Zealand Pharma A/S Glucagon analogues
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
TW201215388A (en) 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
KR101382593B1 (ko) 2010-07-21 2014-04-10 한미사이언스 주식회사 신규한 지속형 글루카곤 결합체 및 이를 포함하는 비만 예방 및 치료용 약학적 조성물
JP6086067B2 (ja) 2010-12-22 2017-03-01 インディアナ ユニヴァーシティ リサーチ アンド テクノロジー コーポレイション Gipレセプター活性を示すグルカゴンアナローグ
EP2665487A1 (en) 2011-01-20 2013-11-27 Zealand Pharma A/S Combination of acylated glucagon analogues with insulin analogues
US9289516B2 (en) * 2011-03-09 2016-03-22 The General Hospital Corporation Imaging beta cell mass
US20140031278A1 (en) 2011-03-28 2014-01-30 Novo Nordisk A/S Novel Glucagon Analogues
WO2012150503A2 (en) 2011-05-03 2012-11-08 Zealand Pharma A/S Glu-glp-1 dual agonist signaling-selective compounds
EP2707713A2 (en) 2011-05-10 2014-03-19 Zealand Pharma A/S Glu-glp-1 dual agonist signaling-selective compounds
CA2839867A1 (en) 2011-06-22 2012-12-27 Indiana University Research And Technology Corporation Glucagon/glp-1 receptor co-agonists
US20140221283A1 (en) 2011-06-22 2014-08-07 Indiana University Research And Technology Corporation Glucagon/glp-1 receptor co-agonists
EP2729493A1 (en) 2011-07-04 2014-05-14 Imperial Innovations Limited Novel compounds and their effects on feeding behaviour
WO2013037390A1 (en) 2011-09-12 2013-03-21 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
EP2567959B1 (en) 2011-09-12 2014-04-16 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013041678A1 (en) 2011-09-23 2013-03-28 Novo Nordisk A/S Novel glucagon analogues
EP2760862B1 (en) 2011-09-27 2015-10-21 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013064669A1 (en) 2011-11-03 2013-05-10 Zealand Pharma A/S Glp-1 receptor agonist peptide gastrin conjugates
KR20140114845A (ko) 2011-12-23 2014-09-29 질랜드 파마 에이/에스 글루카곤 유사체
WO2013098408A1 (en) 2011-12-30 2013-07-04 Zealand Pharma A/S Glucagon and cck receptor agonist peptide conjugates
AR090937A1 (es) 2012-05-03 2014-12-17 Zealand Pharma As Compuestos agonista duales de gip-glp-1 y metodos para usarlos
KR20150023690A (ko) 2012-06-14 2015-03-05 사노피 엑센딘-4 펩타이드 유사체
KR20150032912A (ko) 2012-07-23 2015-03-30 질랜드 파마 에이/에스 글루카곤 유사체
TWI608013B (zh) 2012-09-17 2017-12-11 西蘭製藥公司 升糖素類似物
WO2014049610A2 (en) 2012-09-26 2014-04-03 Cadila Healthcare Limited Peptides as gip, glp-1 and glucagon receptors triple-agonist
AR092925A1 (es) 2012-10-09 2015-05-06 Sanofi Sa Derivados de exendina-4 como agonistas duales de glp1 / glucagon
WO2014064215A1 (en) 2012-10-24 2014-05-01 INSERM (Institut National de la Santé et de la Recherche Médicale) TPL2 KINASE INHIBITORS FOR PREVENTING OR TREATING DIABETES AND FOR PROMOTING β-CELL SURVIVAL
AU2013366692B2 (en) 2012-12-21 2017-11-23 Sanofi Dual GLP1/GIP or trigonal GLP1/GIP/Glucagon agonists
CA2907454A1 (en) 2013-03-21 2014-09-25 Sanofi-Aventis Deutschland Gmbh Synthesis of hydantoin containing peptide products
US10450343B2 (en) 2013-03-21 2019-10-22 Sanofi-Aventis Deutschland Gmbh Synthesis of cyclic imide containing peptide products
WO2014161835A1 (en) 2013-04-03 2014-10-09 Sanofi Modified blood glucose regulating proteins with altered pharmacological activity profile and preparation thereof
CN105307672A (zh) 2013-04-18 2016-02-03 诺和诺德股份有限公司 用于医学用途的稳定、延长的glp-1/胰高血糖素受体共激动剂
ES2688708T3 (es) 2013-10-17 2018-11-06 Zealand Pharma A/S Análogos de glucagón acilados
US9988429B2 (en) 2013-10-17 2018-06-05 Zealand Pharma A/S Glucagon analogues
AU2014345570B2 (en) 2013-11-06 2019-01-24 Zealand Pharma A/S Glucagon-GLP-1-GIP triple agonist compounds
KR20160079875A (ko) 2013-11-06 2016-07-06 질랜드 파마 에이/에스 Gip-glp-1 이원 효능제 화합물 및 방법
WO2015086733A1 (en) 2013-12-13 2015-06-18 Sanofi Dual glp-1/glucagon receptor agonists
WO2015086731A1 (en) 2013-12-13 2015-06-18 Sanofi Exendin-4 peptide analogues as dual glp-1/glucagon receptor agonists
EP3080152A1 (en) 2013-12-13 2016-10-19 Sanofi Non-acylated exendin-4 peptide analogues
EP3080154B1 (en) 2013-12-13 2018-02-07 Sanofi Dual glp-1/gip receptor agonists
EP3080150B1 (en) 2013-12-13 2018-08-01 Sanofi Exendin-4 peptide analogues as dual glp-1/gip receptor agonists
AU2015220909A1 (en) 2014-02-18 2016-07-14 Novo Nordisk A/S Stable glucagon analogues and use for treatment of hypoglycaemia
TW201625669A (zh) 2014-04-07 2016-07-16 賽諾菲公司 衍生自艾塞那肽-4(Exendin-4)之肽類雙重GLP-1/升糖素受體促效劑
TW201625670A (zh) 2014-04-07 2016-07-16 賽諾菲公司 衍生自exendin-4之雙重glp-1/升糖素受體促效劑
TW201625668A (zh) 2014-04-07 2016-07-16 賽諾菲公司 作為胜肽性雙重glp-1/昇糖素受體激動劑之艾塞那肽-4衍生物
JP2017525656A (ja) 2014-06-04 2017-09-07 ノヴォ ノルディスク アー/エス 医療用のglp−1/グルカゴン受容体コアゴニスト
US9932381B2 (en) 2014-06-18 2018-04-03 Sanofi Exendin-4 derivatives as selective glucagon receptor agonists
EP3206710A4 (en) 2014-09-24 2017-12-20 Indiana University Research & Technology Corporation Incretin-insulin conjugates
MX2017005457A (es) 2014-10-29 2017-07-04 Zealand Pharma As Metodos y compuestos agonistas de gip.
US10213487B2 (en) 2015-02-17 2019-02-26 Eli Lilly And Company Nasal powder formulation for treatment of hypoglycemia
CA2979950A1 (en) 2015-03-18 2016-09-22 Zealand Pharma A/S Amylin analogues
WO2016151018A1 (en) 2015-03-24 2016-09-29 INSERM (Institut National de la Santé et de la Recherche Médicale) Method and pharmaceutical composition for use in the treatment of diabetes
CN107636010A (zh) 2015-04-16 2018-01-26 西兰制药公司 酰化胰高血糖素类似物
AR105319A1 (es) 2015-06-05 2017-09-27 Sanofi Sa Profármacos que comprenden un conjugado agonista dual de glp-1 / glucagón conector ácido hialurónico
WO2016198624A1 (en) 2015-06-12 2016-12-15 Sanofi Exendin-4 derivatives as trigonal glp-1/glucagon/gip receptor agonists
WO2016198628A1 (en) 2015-06-12 2016-12-15 Sanofi Non-acylated exendin-4 derivatives as dual glp-1/glucagon receptor agonists
TW201706291A (zh) 2015-07-10 2017-02-16 賽諾菲公司 作為選擇性肽雙重glp-1/升糖素受體促效劑之新毒蜥外泌肽(exendin-4)衍生物
WO2017116205A1 (ko) 2015-12-31 2017-07-06 한미약품 주식회사 글루카곤, glp-1 및 gip 수용체 모두에 활성을 갖는 삼중 활성체의 지속형 결합체
EP3468569A1 (en) * 2016-06-09 2019-04-17 AmideBio LLC Glucagon analogs and methods of use thereof
CN109641035A (zh) * 2016-06-29 2019-04-16 韩美药品株式会社 胰高血糖素衍生物、其缀合物、包含其的组合物、和其治疗用途
MX2019001427A (es) 2016-08-05 2019-06-10 Boehringer Ingelheim Int Derivados de oxadiazolopiridina para el uso como inhibidores de ghrelin o-aciltransferasa (goat).
TW201811818A (zh) 2016-09-09 2018-04-01 丹麥商西蘭製藥公司 澱粉素類似物
AR110299A1 (es) 2016-12-02 2019-03-13 Sanofi Sa Conjugados que comprenden un agonista dual de glp-1 / glucagón, un conector y ácido hialurónico
WO2019149657A1 (en) 2018-02-02 2019-08-08 Boehringer Ingelheim International Gmbh Benzyl-, (pyridin-3-yl)methyl- or (pyridin-4-yl)methyl-substituted oxadiazolopyridine derivatives as ghrelin o-acyl transferase (goat) inhibitors
WO2019149660A1 (en) 2018-02-02 2019-08-08 Boehringer Ingelheim International Gmbh Triazolopyrimidine derivatives for use as ghrelin o-acyl transferase (goat) inhibitors
WO2019149658A1 (en) 2018-02-02 2019-08-08 Boehringer Ingelheim International Gmbh Pyrazole- and indazole-substituted oxadiazolopyridine derivatives for use as ghrelin o-acyl transferase (goat) inhibitors
WO2019149659A1 (en) 2018-02-02 2019-08-08 Boehringer Ingelheim International Gmbh Heterocyclyl-substituted oxadiazolopyridine derivatives for use as ghrelin o-acyl transferase (goat) inhibitors

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ202757A (en) * 1981-12-23 1985-11-08 Novo Industri As Peptides and medicaments
DK0929567T3 (da) 1996-09-09 2005-06-27 Zealand Pharma As Forbedret fastfase-peptidsyntese og middel til anvendelse af en sådan syntese
EP1066314B1 (en) 1997-11-14 2007-12-26 Amylin Pharmaceuticals, Inc. Novel exendin agonist compounds
IL138214D0 (en) 1998-03-09 2001-10-31 Zealand Pharmaceuticals As Pharmacolgically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
EP1076066A1 (en) 1999-07-12 2001-02-14 Zealand Pharmaceuticals A/S Peptides for lowering blood glucose levels
GB0121709D0 (en) * 2001-09-07 2001-10-31 Imp College Innovations Ltd Food inhibition agent
GB0300571D0 (en) 2003-01-10 2003-02-12 Imp College Innovations Ltd Modification of feeding behaviour
ES2385093T3 (es) * 2005-06-13 2012-07-18 Imperial Innovations Limited Análogos de oxintomodulina y sus efectos sobre el comportamiento de la conducta alimentaria
WO2007024899A2 (en) 2005-08-23 2007-03-01 The General Hospital Corporation Use of glp-1, glp-1 derivatives or glp-1 fragments for skin regeneration, stimulation of hair growth, or treatment of diabetes
US8454971B2 (en) 2007-02-15 2013-06-04 Indiana University Research And Technology Corporation Glucagon/GLP-1 receptor co-agonists
EP2025684A1 (en) 2007-08-15 2009-02-18 Zealand Pharma A/S Glucagon analogues

Also Published As

Publication number Publication date
AT520714T (de) 2011-09-15
US20100204105A1 (en) 2010-08-12
WO2008152403A1 (en) 2008-12-18
EP2158214B1 (en) 2011-08-17
EP2158214A1 (en) 2010-03-03
US7994122B2 (en) 2011-08-09
JP5385266B2 (ja) 2014-01-08
JP2010529849A (ja) 2010-09-02

Similar Documents

Publication Publication Date Title
DK2242393T3 (da) Hårstylinghjælpemiddel
DK2209856T3 (da) Aerogelsammensætninger
DK2665193T3 (da) Styrekanalallokering
DK2205737T3 (da) Mikromirer
DK2158214T3 (da) Glukagonanaloger
DK2522667T3 (da) Morphinanforbindelser
DK2196089T3 (da) Fungicidsammensætninger
DK2214679T3 (da) Kortikosteroidsammensætninger
DK2170321T3 (da) Ormekur-kombination
DK2121534T3 (da) Enkeltrudelaminater
DK2124668T3 (da) Hårplejeindretning
AT531723T (de) Steviolglycosidisomere
BRPI0817238A2 (pt) Transconector
DK2514818T3 (da) Glucoamylasevarianter
AT511375T (de) Getränkeaufbrüheinheit
AT530279T (de) Tangentialschneideeinsatz
BRPI0814563A2 (pt) Nanosuperfície
AT544742T (de) Insektizide arylpyrrolidine
AT512633T (de) Wirbelsäulen-verbindungselement
AT513978T (de) Drehsteuervorrichtungsandockstation
DE602008004224D1 (de) Rfahren
AT545790T (de) Gelenklager
DE602008002066D1 (de) Iorekonstruktion
AT498456T (de) Katalysatorträgerwabe
AT519240T (de) Batterieseparatorstrukturen